Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04855487 · ClinicalTrials.gov registry record · NA

Expressive Storytelling to Share Adolescents/Young Adults Cancer Stories

A NA study of Pediatric Cancer and Nurse-Patient Relations, sponsored by Vanderbilt University.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT04855487: Completed NA study of Pediatric Cancer and Nurse-Patient Relations, sponsored by Vanderbilt University.

NCT04855487 is a NA study of Pediatric Cancer and Nurse-Patient Relations that has completed, run by Vanderbilt University. The registered enrollment target is 15 participants, below the 1,490-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04855487, a NA study of Pediatric Cancer and Nurse-Patient Relations, has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test the feasibility, acceptability, and preliminary efficacy of an online expressive storytelling intervention for adolescents and young adults (AYA) with cancer. * Specific Aim 1. To evaluate the feasibility and acceptability of a 5-week online expressive storytelling intervention. We will (a) conduct a 1-group pre- and post-test study with 20 AYA with cancer and (b) examine feasibility and acceptability through study enrollment rates, retention rates, usability score, adherence and data collection rates, satisfaction score, perceived benefits score, and intervention fidelity. \*Hypothesis 1: We will reach following feasibility and acceptability benchmarks: (a) \>70% enrollment of eligible participants, (b) \>70% retention, (c) \>75% adherence and data collection, (d) \>70 out of 100 usability score, (e) \>5 out of 7 satisfaction score, (f) \>average 5 on the perceived benefits score, and (g) \>3 out of 4 fidelity score. * Specific Aim 2. To assess preliminary efficacy of a 5-week online expressive storytelling intervention. * Hypothesis 2: AYA participants will report lower psychosocial distress, higher health-related quality of life, and higher well-being scores postintervention.

Primary Outcome

A 12-item 10-point Likert scale measure ranging from 0 (Not Satisfied at Aall) to 10 (Completely Satisfied) to assess adolescents' level of human flourishing. This measure is tailored to adolescents (12-18 years old).

Interventions

  • BEHAVIORAL Nurse-patient dyadic storytelling intervention

Study Locations (1)

Tennessee

  • Vanderbilt-Ingram Cancer Center - Nashville

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2021-11-10
Est. Completion 2022-05-01
Phase NA
Vanderbilt University

430 total trials

What the finished NCT04855487 record still lists

NCT04855487 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,490-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (99% lower).

The record links to 4 conditions, with Pediatric Cancer appearing as the primary indexed condition, and to 1 intervention - of which Nurse-patient dyadic storytelling intervention is the first listed.

NCT04855487 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT04855487 about?

NCT04855487 is a clinical study titled "Expressive Storytelling to Share Adolescents/Young Adults Cancer Stories". The purpose of this study is to test the feasibility, acceptability, and preliminary efficacy of an online expressive storytelling intervention for adolescents and young adults (AYA) with cancer. * Specific Aim 1. To evaluate the feasibility and acceptability of a 5-week online expressive storytell...

What is the current status of trial NCT04855487?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2021-11-10. Estimated completion is 2022-05-01.

What conditions does trial NCT04855487 study?

This clinical trial studies the following conditions: Pediatric Cancer, Nurse-Patient Relations, Narrative Medicine, Growth, Posttraumatic.

What interventions are being tested in trial NCT04855487?

The interventions under investigation include: Nurse-patient dyadic storytelling intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04855487?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04855487 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pediatric Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04855487's enrollment target sits among peer trials

15 46th of 51 higher than 5 of 51 other Pediatric Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pediatric Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04855487, the US trial registry maintained by the National Library of Medicine. NCT04855487 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.